MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2025 International Congress

    Variations of Self-Perceived Cognitive Changes by Ethnicity in Parkinson’s Disease Patients

    H. Lee, P. Parekh, A. Arroyo, I. Balbo, A. Fanning, R. Alcalay, J. Agin-Liebes (New York, USA)

    Objective: To study perceptions of cognitive function across ethnic groups by comparing a subjective rating with an objective assessment for patients with PD (PWP). Background:…
  • 2025 International Congress

    Tendencies of Non-Motor Symptoms and Short-Term Clinical Predictors in Patients with Parkinson’s Disease

    R. Nakagawa, M. Shiraishi, N. Takao, H. Matsumoto (Kawasaki City, Kanagawa Prefecture, Japan)

    Objective: This study retrospectively investigated whether the occurrence of non-motor symptoms and the decline in cognitive function in patients with Parkinson’s disease (PD) influence fall…
  • 2025 International Congress

    Predictors of Cognitive Impairments and Mood Disorders after Subthalamic Deep Brain Stimulation in Patients with Parkinson’s Disease

    O. Alenikova, M. Dymkovskaya, A. Bunyak, E. Mykitchuk, S. Kantsevich (Minsk, Belarus)

    Objective: We aimed to determine the predictors of cognitive decline and mood disorders after STN-DBS in PD. Background: Cognitive impairment and mood disorders are the…
  • 2025 International Congress

    Schindler Disease (a Rare Autosomal Recessive Lysosomal Storage Disorder)

    SH. Elgamal, E. Fahmy, M. Ragab (Kafrelsheikh, Egypt)

    Objective: This case report discusses the diagnostic difficulties and treatment strategies for Schindler disease type III and provides insightful information on its clinical manifestations Background:…
  • 2025 International Congress

    Phase I randomized, double-blind study to evaluate feasibility, safety, and clinical responses of implanting autologous peripheral nerve tissue into the nucleus basalis of Meynert or substantia nigra for non-motor or motor symptoms in patients with Parkinson’s disease undergoing DBS surgery (STAR) Trial

    J. Quintero, J. Slevin, J. Hixson, G. Gerhardt, C. van Horne (Lexington, USA)

    Objective: To evaluate the feasibility, safety, and clinical responses of bilateral delivery, at the time of deep brain stimulation (DBS) surgery, of autologous peripheral nerve…
  • 2025 International Congress

    Modified Delphi consensus approach to develop recommendations for diagnosis, evaluation and management of cognitive disorders in Parkinson’s disease

    D. Pourzinal, D. Brooks, D. Sriram, L. Mitchell, N. Pachana, K. Shrubsole, B. Wood, J. O'Sullivan, R. Marsh, A. Lehn, J. Liddle, E. Tan, WK. Halford, N. Page, N. Dissanayaka (HERSTON, Australia)

    Objective: We aimed to develop harmonised recommendations for the diagnosis, evaluation and management of cognitive disorders in PD using a modified Delphi process. Background: Differences…
  • 2025 International Congress

    Changes in Cognitive Function with Deep Brain Stimulation in PD patients with and without Freezing of Gait

    V. Basavatia, K. Kwei (New York, USA)

    Objective: To determine if deep brain stimulation (DBS) changes cognitive function in Parkinson’s Disease (PD), and if these cognitive changes may relate to gait dysfunction…
  • 2025 International Congress

    Orthostatic Hypotension and Acute Cognitive Dysfunction in Parkinson’s Disease: Insights from fNIRS

    K. Longardner, P. Reddy, M. Skipworth, D. Salmon, K. Izzetoglu, I. Litvan (La Jolla, USA)

    Objective: To define cerebral oxygenation changes during positional cognitive testing in Parkinson’s disease (PD), comparing those with orthostatic hypotension (OH+) to those without (OH-). Background:…
  • 2025 International Congress

    Impaired Speech Perception in Noise (SPiN), Hearing Loss, and Cholinergic Denervation in Parkinson’s Disease

    S. Roytman, D. Mccaslin, J. Barr, R. Vangel, P. Kanel, N. Bohnen (Ann. Arbor, USA)

    Objective: This study will investigate the relationships among speech-perception-in-noise (SPiN), hearing acuity, and cholinergic system changes in patients with PD. Background: Recent studies highlight a…
  • 2025 International Congress

    Delirium following deep brain stimulation: An 8 year single-centre study

    S. Farrand, T. Reilly, C. Monahan, G. Nair, J. Hannan, R. Blaze, M. Ghaly, K. Gomes, K. Hamilton, W. Lee, D. Thyagarajan, A. Gilligan, A. Evans (Melbourne, Australia)

    Objective: To describe the outcomes of patients undergoing deep brain stimulation (DBS) surgery for movement disorders and neuropsychiatric indications and characterise delirium symptoms. Background: Deep…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley